Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Yuhan in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
Current Consensus is
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in Yuhan. This N/A consensus rating has held steady for over two years.
Yuhan
Yuhan Corp. engages in the manufacture of pharmaceutical, health foods, cosmetics and consumer products. It operates through the following business areas: Pharmaceutical, Household products and Active Pharmaceutical Ingredient (API). Its products include APIs and intermediates and finished products such as ethical drugs, over-the-counter drugs and others. Its services include custom development and manufacturing services and supply chain management. The company was founded by Il-Han New on June 20, 1926 and is headquartered Seoul, South Korea.
Read More